To investigate systematic metabolic biomarkers for early diagnosis of glucose-well-controlled DM patients who still developed diabetic retinopathy (GW-DR) and explore potential biomarker-based precise
The study of proteins circulating in blood offers tremendous opportunities to diagnose, stratify, or possibly prevent diseases. With recent technological advances and the urgent need to understand the
Sequence and structural alterations together with tumor mutation burden (TMB) and microsatellite instability (MSI) have been identified as biomarkers for the determination of response to targeted and